Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I

被引:21
作者
Olivier, A
Lucie, K
Jean-François, R
Christian-Jacques, L
Paule, S
机构
[1] Inst Biol Mol & Ingn Genet, IBMIG, F-86022 Poitiers, France
[2] UFR Pharm, F-51096 Reims, France
关键词
p14(ARF); topoisomerase I; protein interactions; cell cycle;
D O I
10.1038/sj.onc.1206214
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We recently reported an interaction between the p14(ARF). protein and human topoisomerase I (Topo 1) resulting in the stimulation of the relaxation activity of Topo 1. Our data showed that the complex between the two proteins was located within the nucleolus. In the present work, we have investigated the regions of p14(ARF). involved in this interaction by using targeted point mutagenesis and deletion mutants. A region encompassing exon 2-encoded sequence was required for physical binding of p14(ARF) to Topo I as well as for stimulatory activity of the enzyme. Exon 1beta-encoded segment was not implicated in the interaction. Moreover, among p14(ARF) point mutants selected for their high conservation among different mammalian species, mutant p14(ARF) (RR87, 88AA) did not stimulate Topo I in spite of its association with the enzyme, suggesting its direct implication in the functional activity of ARE In contrast, one mutant,p14(ARF) (R71A), was more efficient than wild-type protein to activate Topo 1, suggesting that this residue is a key element to modulate Topo I activity. Finally, only ARF-Topo I complexes containing p14(ARF) exon 2 segment were found to be localized in the nucleolus, suggesting that this sulmuclear location is linked to the biological function of the ARF-Topo I complex.
引用
收藏
页码:1945 / 1954
页数:10
相关论文
共 22 条
  • [1] p16INK4A and p19ARF act in overlapping pathways in cellular immortalization
    Carnero, A
    Hudson, JD
    Price, CM
    Beach, DH
    [J]. NATURE CELL BIOLOGY, 2000, 2 (03) : 148 - 155
  • [2] The human protein p19(ARF) is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16(INK4a)/MTS1 gene
    DellaValle, V
    Duro, D
    Bernard, O
    Larsen, CJ
    [J]. ONCOGENE, 1997, 15 (20) : 2475 - 2481
  • [3] Gazzeri S, 1998, CANCER RES, V58, P3926
  • [4] SCL 70 AUTOANTIBODIES FROM SCLERODERMA PATIENTS RECOGNIZE A 95 KDA PROTEIN IDENTIFIED AS DNA TOPOISOMERASE-I
    GULDNER, HH
    SZOSTECKI, C
    VOSBERG, HP
    LAKOMEK, HJ
    PENNER, E
    BAUTZ, FA
    [J]. CHROMOSOMA, 1986, 94 (02) : 132 - 138
  • [5] Modelling the molecular circuitry of cancer
    Hahn, WC
    Weinberg, RA
    [J]. NATURE REVIEWS CANCER, 2002, 2 (05) : 331 - 341
  • [6] A GENERAL-METHOD OF INVITRO PREPARATION AND SPECIFIC MUTAGENESIS OF DNA FRAGMENTS - STUDY OF PROTEIN AND DNA INTERACTIONS
    HIGUCHI, R
    KRUMMEL, B
    SAIKI, RK
    [J]. NUCLEIC ACIDS RESEARCH, 1988, 16 (15) : 7351 - 7367
  • [7] Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19(ARF)
    Kamijo, T
    Zindy, F
    Roussel, MF
    Quelle, DE
    Downing, JR
    Ashmun, RA
    Grosveld, G
    Sherr, CJ
    [J]. CELL, 1997, 91 (05) : 649 - 659
  • [8] Human ARF protein interacts with Topoisomerase I and stimulates its activity
    Karayan, L
    Riou, JF
    Séité, P
    Migeon, J
    Cantereau, A
    Larsen, CJ
    [J]. ONCOGENE, 2001, 20 (07) : 836 - 848
  • [9] KUBBUTAT MH, 1997, NATURE, V6630, P299
  • [10] p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts
    Kurokawa, K
    Tanaka, T
    Kato, J
    [J]. ONCOGENE, 1999, 18 (17) : 2718 - 2727